N-氰基-N'-甲基乙脒 | 19355-69-2

• 物质功能分类: 化学试剂 - 有机试剂 - 氰化物/腈
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-氰基-N'-甲基乙脒
• 中文别名: 2-氨基-2-甲基丙腈；N-氰基-N’-甲基乙脒；2-氨基-2-甲基丙腈盐酸盐；N-氰基-N`-甲基乙脒；2-氨基-2-甲基丙烷腈；2,2-二甲基乙腈胺；N-氰基-N"-甲基乙脒
• 英文名称: 2-amino-2-cyanopropane
• 英文别名: 2-amino-2-methylpropanenitrile；2-amino-2-methylpropionitrile
• CAS: 19355-69-2
• 化学式: C₄H₈N₂
• mdl: MFCD00043024
• 分子量: 84.1209
• InChiKey: JQULXIOYDDCNGR-UHFFFAOYSA-N

物化性质

• 沸点：
  51-52 °C(Press: 15 Torr)
• 密度：
  0.885 g/cm3(Temp: 25 °C)
• 溶解度：
  DMSO（少量）、甲醇（少量）
• 物理描述：
  Liquid
• 稳定性/保质期：

  本品是一种油状液体，不溶于水，但能溶解在有机溶剂中。

计算性质

• 辛醇/水分配系数(LogP)：
  -0.3
• 重原子数：
  6
• 可旋转键数：
  0
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 安全说明：
  S26,S36/37/39
• 危险类别码：
  R20/21/22
• 危险品运输编号：
  3276
• 海关编码：
  2926909090
• 危险类别：
  IRRITANT
• 储存条件：
  -20°C 冷冻储存，惰性气氛环境下

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Amino-2-methylpropanenitrile
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H301: Toxic if swallowed
H315: Causes skin irritation
H317: May cause an allergic skin reaction
H318: Causes serious eye damage
May cause respiratory irritation
H335:
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
P280: Wear protective gloves/protective clothing/eye protection/face protection
P301+P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-2-methylpropanenitrile
CAS number: 19355-69-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C4H8N2
Molecular weight: 84.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
UN Number: UN2811 Class: 6.1 Packing group: III
Proper shipping name: TOXIC SOLIDS, ORGANIC, N.O.S. (2-Amino-2-methylpropanenitrile)

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

化学性质： 本品为油状液体，不溶于水但能溶解于有机溶剂。

用途： 2,2-二甲基乙腈胺是除草剂氰草津的中间体，并且用于生产杀虫剂啶虫脒。

生产方法： 其制备方法是由氰化钾或氰化钠与丙酮在硫酸和水中于20℃反应得到2-甲基-2-羟基丙腈，再进一步氨化而制得。

反应信息

• 作为反应物：
  描述：

  N-氰基-N'-甲基乙脒 在 十六烷基三甲基氯化铵 作用下， 以gave 2,2'-azobis(2-methylpropanenitrile) in the yields的产率得到偶氮二异丁腈
  参考文献：
  名称：

  Process for the preparation of aliphatic azo compounds using an amine

  摘要：

  描述了一种制备式I化合物的过程，其中至少R1、R2和R3中的每一个，以及R4、R5和R6中的每一个，代表一个电子吸引基团，或者R1、R2和R3中的一个与R4、R5和R6中的一个形成一个--CO--基团，而R1、R2、R3、R4、R5和R6的其余部分，可以相同也可以不同，每个都代表一个电子吸引基团、烷基、环烷基、苯基或苯基烷基，或者R1和R2、R4和R5，以及R1和R4，可以共同形成一个--（CH2）n--链，其中n是一个整数，最多为5，烷基、环烷基、苯基或苯基烷基或--（CH2）n--链可选地被取代，包括在碱和表面活性剂存在下，在水介质中反应式II化合物和式III化合物的过程。

  公开号：

  US04546174A1
• 作为产物：
  描述：

  氰化钾 在 氯化铵 作用下， 生成 N-氰基-N'-甲基乙脒
  参考文献：
  名称：

  Zelinsky; Stadnikow, Chemische Berichte, 1906, vol. 39, p. 1726

  摘要：

  DOI：

文献信息

• Novel phenyl-substituted imidazolidines, process for preparation thereof, medicaments comprising said compounds and use thereof
  申请人：JAEHNE Gerhard

  公开号：US20110178134A1

  公开（公告）日：2011-07-21

  The invention relates to compounds of formula (I) wherein the groups have stated meanings, and to their physiologically compatible salts. Said compounds are suitable, for example, as anti-obesity drugs and for treating cardiometabolic syndrome.

  本发明涉及具有所述意义的公式（I）的化合物，以及它们的生理相容性盐。所述化合物适用于例如作为抗肥胖药物和治疗心血管代谢综合征。
• Studies into the synthesis of derivatives of 4-amino-2,3-dihydroisothiazole 1,1-dioxides and 4-amino-1,2-oxathiole 2,2-dioxides: The search for linked π-system containing analogues as potential inhibitors of HIV-1 reverse transcriptase
  作者：Simon T. Ingate、JoséL. Marco、Myriam Witvrouw、Cristophe Pannecouque、Erik De Clercq

  DOI：10.1016/s0040-4020(97)10244-7

  日期：1997.12

  The synthesis, and anti HIV-1 activity, of new derivatives of 4-amino-1,2-oxathiole 2,2-dioxide (3, 5, 6 and 9) and 4-amino-2,3-dihydroisothiazole 1,1-dioxide (14), a new heterocyclic ring system, is described.

  合成，和抗HIV-1活性，新衍生物的4-氨基-1,2- oxathiole 2,2-二氧化物（3，5，6和9）和4-氨基-2,3-二dihydroisothiazole 1,1描述了新的杂环系统-二氧化物（14）。
• Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C
  作者：Daniel Guay、Christian Beaulieu、T. Jagadeeswar Reddy、Robert Zamboni、Nathalie Methot、Joel Rubin、Diane Ethier、M. David Percival

  DOI：10.1016/j.bmcl.2009.07.114

  日期：2009.9

  A series of dipeptide nitriles with a thienyl alanine in P2 were identified as potent and selective cathepsin C inhibitors. Incorporation of a substituted cyclopropyl moiety in P1 effectively protects these derivatives against hydrolase activity in whole blood.

  一系列在P2中带有噻吩丙氨酸的二肽腈被确定为有效的和选择性的组织蛋白酶C抑制剂。在P1中引入取代的环丙基部分可有效保护这些衍生物免于全血中的水解酶活性。
• Prebiotic selection and assembly of proteinogenic amino acids and natural nucleotides from complex mixtures
  作者：Saidul Islam、Dejan-Krešimir Bučar、Matthew W. Powner

  DOI：10.1038/nchem.2703

  日期：2017.6

  permits ribonucleotide synthesis, even from complex sugar mixtures. Remarkably, aminal formation also overcomes the thermodynamically favoured isomerization of glyceraldehyde into dihydroxyacetone because only the aminal of glyceraldehyde separates from the equilibrating mixture. Finally, we show that aminal formation provides a novel pathway to amino acids that avoids the synthesis of the non-proteinogenic

  益生元合成生物氨基酸和核苷酸的主要问题是避免伴随合成不希望的或不相关的副产物。另外，多步路径需要能够使反应物顺序添加和纯化中间体的机制，这与合理的地球化学情况一致。在这里，我们表明2-氨基噻唑与二碳糖和三碳糖（分别为甘醇醛和甘油醛）选择性反应，从而导致它们的积累和纯化为稳定的结晶类缩醛胺。这允许甚至从复杂的糖混合物中合成核糖核苷酸。值得注意的是 氨醛的形成还克服了甘油醛热力学上有利于异构化为二羟基丙酮的异构化问题，因为只有甘油醛的氨醛才从平衡混合物中分离出来。最后，我们表明氨基形成为氨基酸提供了一种新颖的途径，从而避免了非蛋白质生成的α，α-二取代类似物的合成。控制益生元混合物中蛋白质氨基酸和核糖核苷酸装配的常见物理化学机制表明，这些必需的代谢物类别具有统一的化学起源。
• Methods and compositions for treating amyloid-related diseases
  申请人：Kong Xianqi

  公开号：US20060223855A1

  公开（公告）日：2006-10-05

  Methods, compounds, pharmaceutical compositions and kits are described for treating or preventing amyloid-related disease.

  描述了用于治疗或预防与淀粉样蛋白相关疾病的方法、化合物、药物组合物和试剂盒。